Wang et al. [26] treated LNCaP cells with the androgen receptor antagonist flutamide and found that BTG1 mRNA expression was upregulated, indicating that BTG1 overexpression might be involved in the enhancement of chemotherapeutic sensitivity in cancers. The gene discussed is AR; the disease is cancer.